Skip to main content
    H

    Health Catalyst Inc (HCAT)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.74
    -0.01 (-0.57%)

    Market Cap: $130.95M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    79%(23/29)
    Avg Surprise
    +72.59%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.05
    Range$-0.07 - $-0.02
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.00-11775.0%
    60d ago$-0.00-11775.0%
    30d ago$-0.05+11.4%
    7d ago$-0.05+11.4%
    Current$-0.05
    Revenue Consensus
    $55M
    Range$55M - $56M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.06 - $0.01
    4 analysts
    Revenue Consensus
    $54M
    Range$53M - $57M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.05---
    Jun 26
    Reported Aug 6
    		$-0.08$-0.05-60.00%Miss+0.0%
    Mar 26
    Reported May 11
    		$0.02$0.01+100.00%Beat+100.0%
    Dec 25
    Reported Mar 12
    		$0.08$0.10-16.14%Miss+100.0%
    Sep 25
    Reported Nov 10
    		$0.06$0.07-14.29%Miss-14.3%
    Jun 25
    Reported Aug 7
    		$-0.08$-0.09+11.11%Beat-166.7%
    Mar 25
    Reported May 7
    		$0.01N/A-66.67%Miss-80.0%
    Dec 24
    Reported Feb 26
    		$0.04$0.08-47.64%Miss+100.0%
    Sep 24
    Reported Nov 6
    		$0.07$0.09-22.22%Miss+133.3%
    Jun 24
    Reported Aug 7
    		$0.12$0.08+50.00%Beat+140.0%
    Mar 24
    Reported May 9
    		$0.05$0.03+66.67%Beat+0.0%
    Dec 23
    Reported Feb 22
    		$0.02$-0.01+300.00%Beat+140.0%
    Sep 23
    Reported Nov 2
    		$0.03$-0.01+400.00%Beat+123.1%
    Jun 23
    Reported Aug 8
    		$0.05$-0.01+600.00%Beat+266.7%
    Mar 23
    Reported May 9
    		$0.05$-0.04+225.00%Beat+183.3%
    Dec 22
    Reported Feb 28
    		$-0.05N/A+54.55%Beat+73.7%
    Sep 22
    Reported Nov 8
    		$-0.13$-0.19+31.58%Beat+27.8%
    Jun 22
    Reported Aug 4
    		$-0.03N/A+66.67%Beat-1664.7%
    Mar 22
    Reported May 10
    		$-0.06$-0.11+45.45%Beat+0.0%
    Dec 21
    Reported Mar 1
    		$-0.19$-0.21+9.52%Beat-18.8%
    Sep 21
    Reported Nov 9
    		$-0.18$-0.22+18.18%Beat+14.3%
    Jun 21
    Reported Aug 5
    		$-0.00N/A+98.79%Beat+98.9%
    Mar 21
    Reported May 6
    		$-0.06N/A+57.14%Beat+62.5%
    Dec 20
    Reported Feb 25
    		$-0.16$-0.19+15.79%Beat+23.8%
    Sep 20
    Reported Nov 10
    		$-0.21$-0.27+22.22%Beat+22.2%
    Jun 20
    Reported Aug 11
    		$-0.15$-0.22+31.82%Beat+28.6%
    Mar 20
    Reported May 12
    		$-0.16$-0.26+38.46%Beat+92.6%
    Dec 19
    Reported Feb 27
    		$-0.21$-0.29+27.59%Beat-
    Sep 19
    Reported Nov 12
    		$-0.27$-0.37+27.03%Beat-
    Jun 19
    Reported Jul 25
    		$-0.21$-0.32+34.38%Beat-
    Mar 19
    Reported Apr 10
    		$-2.17$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio21.75EV/EBITDAN/A
    Price/FCF4.76xFCF Yield21.00%
    Profitability
    Profit Margin-90.60%Operating Margin-5.35%
    ROE-118.10%ROIC-96.95%
    Financial Health
    Debt/Equity1.52xInterest CoverageN/A
    Current Ratio2.70xQuick Ratio2.70x
    Trading Statistics
    Beta1.54Avg Volume473.87K
    52-Week High$3.6252-Week Low$0.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.75
    SMA 20$1.76
    SMA 50$1.76
    SMA 200$1.76
    EMA 10$1.75
    EMA 20$1.75
    EMA 50$1.77
    EMA 200$1.95

    MACD

    Line: -0.00Signal: -0.00Hist: 0.00

    ADX

    ADX: 9.6+DI: 16.4-DI: 18.0

    Aroon & PSAR

    Aroon Up40.0
    Aroon DownN/A
    PSAR$1.86

    Bollinger Bands

    Upper Band$1.84
    Lower Band$1.68
    %B Position914%(Upper)
    Band Width0.37

    RSI (14-Day)

    Neutral
    48.1

    Momentum Oscillators

    Stoch %K40.9
    Stoch %D35.7
    Williams %R-47.1
    ROC (10d)-0.6%
    Momentum-0.01
    CCI (20d)-90.5
    MFI (14d)41.8

    Volatility Measures

    ATR (14d)$0.09(5.0%)
    StdDev (20d)0.04
    Hist Vol43.3%(High)

    Volume Flow

    VWAP$1.73
    OBV8.3M
    AD Line-3.1M
    CMF (20d)0.309

    Volume Metrics

    Avg Vol (20d)462.1K
    Vol Ratio2.8x(High)
    VWMA (20d)$1.76

    Pivot Points

    R3$1.87
    R2$1.83
    R1$1.79
    Pivot Point$1.75
    S1$1.71
    S2$1.67
    S3$1.63

    Advanced Oscillators

    TSI-1.00
    Ultimate Osc58.3
    KST21.73

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$70.49M$70.76M$74.68M$76.32M$80.72M$79.41M$79.61M$76.35M$75.90M$74.72M$75.08M$73.77M
    Cost of Revenue$35.63M$35.29M$35.30M$38.51M$42.48M$43.18M$44.91M$42.31M$40.06M$38.52M$44.58M$41.79M
    Gross Profit$34.86M$35.46M$39.38M$37.82M$38.24M$36.23M$34.69M$34.04M$35.84M$36.21M$30.51M$31.99M
    Operating Expenses$71.34M$141.94M$125.46M$55.33M$75.33M$56.41M$52.19M$47.73M$51.65M$59.02M$63.29M$56.57M
    R&D$11.03M$9.78M$9.91M$12.28M$12.39M$15.19M$15.00M$14.19M$13.88M$14.87M$20.29M$17.67M
    SG&A$11.93M$13.96M$11.04M$16.07M$8.28M$14.16M$15.68M$12.21M$14.36M$14.56M$15.43M$13.63M
    Operating Income$-36,480,000$-106,477,000$-86,080,000$-17,509,000$-37,094,000$-20,171,000$-17,500,000$-13,687,000$-15,807,000$-22,812,000$-32,785,000$-24,580,000
    Interest Income$-3,742,000$-4,135,000$-4,566,000$-4,679,000$-3,803,000$-3,356,000$-2,548,000$-1,514,000$2.36M$2.34M$2.62M$2.61M
    Interest Expense$3.74M$4.13M$4.57M$4.68M$3.80M$3.36M$2.55M$1.51M$0$0$0$0
    Income Before Tax$-40,222,000$-110,612,000$-90,646,000$-22,188,000$-40,897,000$-23,527,000$-20,048,000$-15,201,000$-13,446,000$-20,474,000$-30,169,000$-21,973,000
    Income Tax Expense$315,000$414,000$379,000$41,000$81,000$215,000$625,000$-475,000$70,000$113,000$143,000$59,000
    Net Income$-40,537,000$-111,026,000$-91,025,000$-22,229,000$-40,978,000$-23,742,000$-20,673,000$-14,726,000$-13,516,000$-20,587,000$-30,312,000$-22,032,000
    EBITDA$-25,255,000$-93,956,000$-72,666,000$-4,423,000$-23,548,000$-7,557,000$-6,914,000$-3,136,000$-5,953,000$-13,873,000$-25,006,000$-16,829,000
    EBIT$-36,480,000$-106,477,000$-86,080,000$-17,509,000$-37,094,000$-20,171,000$-17,500,000$-13,687,000$-15,807,000$-22,812,000$-32,785,000$-24,580,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HCAT

    HCAT Valuation and Fair Value

    P/E
    21.8x
    Forward P/E
    10.0x
    P/FCF
    4.8x
    P/B
    1.3x
    See GNG's fair value

    HCAT Profitability: Margins, ROIC and FCF

    Gross margin
    50.5%
    Operating margin
    -5.3%
    Net margin
    -90.6%
    ROIC
    -96.9%
    ROE
    -118.1%
    FCF margin
    9.2%
    FCF yield
    21.0%

    HCAT Competitors

    CompanyTicker
    Voyager Therapeutics IncVYGR
    Korro Bio, Inc.KRRO
    Tiziana Life Sciences LtdTLSA
    OrganiGram Holdings IncOGI
    AN2 Therapeutics IncANTX
    MaxCyte IncMXCT
    Owlet IncOWLT
    NyxoahNYXH

    Sector: Healthcare

    HCAT Analyst Ratings

    Consensus
    Hold
    Analysts
    6
    Strong Buy
    0
    Buy
    1
    Hold
    5
    Sell
    0
    Strong Sell
    0

    HCAT Bull Case vs Bear Case

    Bear case

    • HCAT has a -90.6% net profit margin.
    • HCAT beat EPS estimates in 25.0% of its last 8 reported quarters.
    • HCAT's quarterly revenue changed -12.7% year over year.

    HCAT Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -14.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.05
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About HCAT

    Does HCAT pay dividends?

    Health Catalyst Inc (HCAT) does not currently pay a regular dividend.

    What is HCAT's P/E ratio?

    Health Catalyst Inc has a price-to-earnings (P/E) ratio of 21.75.

    What is HCAT's market cap?

    Health Catalyst Inc (HCAT) has a market capitalization of $130.95M with a current stock price of $1.74.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In